Keeping new antifungals as second-line agents only
Arch Oral Biol
.
2011 Nov;56(11):1179-80.
doi: 10.1016/j.archoralbio.2011.05.011.
Epub 2011 Jun 17.
Author
Wil van der Reijden
PMID:
21683941
DOI:
10.1016/j.archoralbio.2011.05.011
No abstract available
Publication types
Editorial
MeSH terms
Antifungal Agents / therapeutic use*
Aspergillosis / drug therapy
Candidiasis / drug therapy
Drug Resistance, Fungal*
Humans
Opportunistic Infections / drug therapy
Species Specificity
Substances
Antifungal Agents